SCHEMBL1471015

SCHEMBL1471015

FC(F)(F)c1cnc(Cl)cc1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3R1 P27986 1/20 0.38
PIK3CA P42336 1/20 0.38
ASPH Q12797 1/20 0.36
NOTUM Q6P988 4/20 0.36
PIK3CD O00329 1/20 0.36
MBOAT4 Q96T53 1/20 0.35
ALDH1A1 P00352 2/20 0.35
KCNQ3 O43525 2/20 0.35
KCNQ2 O43526 2/20 0.35
KCNE1 P15382 2/20 0.35
KCNQ1 P51787 2/20 0.35
KMO O15229 2/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
JUN P05412 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
PLAU P00749 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30433748 1.00 PIK3R1 (0.38) PIK3R1PIK3CAASPHNOTUMPIK3CD
SCHEMBL3840400 0.84 PIK3R1 (0.42) PIK3R1PIK3CAASPHNOTUMPIK3CD
SCHEMBL31280670 0.83 RXRA (0.31) PIK3R1PIK3CAALDH1A1
SCHEMBL1515470 0.82 PIK3R1 (0.41) PIK3R1PIK3CANOTUMPIK3CDALDH1A1
SCHEMBL29435663 0.82 PIK3R1 (0.41) PIK3R1PIK3CANOTUMPIK3CDALDH1A1
SCHEMBL1470507 0.79 TSHR (0.43)
SCHEMBL30833531 0.79 TSHR (0.43)
SCHEMBL19616271 0.78 PIK3CD (0.38) ASPHNOTUMPIK3CDMBOAT4ALDH1A1
SCHEMBL22557297 0.78 PIK3CD (0.49) PIK3R1PIK3CAPIK3CDMBOAT4ALDH1A1
SCHEMBL432680 0.78 PIK3R1 (0.36) PIK3R1PIK3CAASPHNOTUMPIK3CD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 141 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12552777-B2 Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof ENANTA PHARMACEUTICALS, INC. (US) 2026-02-17 US disclosed
US-12331065-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2025-06-17 US disclosed
US-12331237-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2025-06-17 US disclosed
US-20240376079-A1 Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use Thereof ENANTA PHARM INC (US) 2024-11-14 US disclosed
US-12018017-B2 Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof ENANTA PHARMACEUTICALS, INC. (US) 2024-06-25 US disclosed
US-12018017-B2 Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof ENANTA PHARMACEUTICALS, INC. (US) 2024-06-25 US disclosed
US-20230365606-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-11-16 US disclosed
US-20230365606-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-11-16 US disclosed
US-20230365606-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-11-16 US disclosed
EP-3621615-B1 APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS AND METHODS OF USE THEREOF ENANTA PHARM INC (US) 2023-11-15 EP disclosed
US-7494999-B2 Sulfonyl-substituted bicyclic compounds as modulators of PPAR KALYPSYS, INC (US) 2009-02-24 US disclosed
US-7494999-B2 Sulfonyl-substituted bicyclic compounds as modulators of PPAR KALYPSYS, INC (US) 2009-02-24 US disclosed
US-7494999-B2 Sulfonyl-substituted bicyclic compounds as modulators of PPAR KALYPSYS, INC (US) 2009-02-24 US disclosed
US-20090029971-A1 SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS MODULATORS OF PPAR KALYPSYS, INC. (US) 2009-01-29 US disclosed
US-20090029971-A1 SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS MODULATORS OF PPAR KALYPSYS, INC. (US) 2009-01-29 US disclosed
US-20090029971-A1 SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS MODULATORS OF PPAR KALYPSYS, INC. (US) 2009-01-29 US disclosed
EP-1805158-A1 SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS MODULATORS OF PPAR Kalypsys, Inc. (US) 2007-07-11 EP disclosed
US-20060205736-A1 Sulfonyl-substituted bicyclic compounds as modulators of PPAR KALYPSYS, INC. 2006-09-14 US disclosed
US-20060167012-A1 Sulfonyl-substituted bicyclic compounds as modulators of PPAR KALYPSYS, INC. 2006-07-27 US disclosed
WO-2006055187-A1 SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS MODULATORS OF PPAR KALYPSYS, INC. (US) 2006-05-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552777-B2 Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof AIFM1, BAD, IRAK1 PIK3R1 1225/4885PIK3CA 2160/4885ASPH 3983/4885
US-20060167012-A1 Sulfonyl-substituted bicyclic compounds as modulators of PPAR PPARG, PPARA, PPARD PIK3R1 1336/4885PIK3CA 1921/4885ASPH 3890/4885
US-20240376079-A1 Apoptosis Signal-Regulating Kinase 1 Inhibitors and Methods of Use Thereof BAD, CASP1, BAX PIK3R1 1426/4885PIK3CA 1906/4885ASPH 2231/4885
US-12331237-B2 Organic electroluminescent materials and devices CTCF, RUVBL2, RUVBL1 PIK3R1 4569/4885PIK3CA 4632/4885ASPH 3812/4885
US-20090029971-A1 SULFONYL-SUBSTITUTED BICYCLIC COMPOUNDS AS MODULATORS OF PPAR PPARG, PPARA, PPARD PIK3R1 1336/4885PIK3CA 1921/4885ASPH 3890/4885
US-12331065-B2 Organic electroluminescent materials and devices CTCF, CCNY, RUVBL2 PIK3R1 4646/4885PIK3CA 4679/4885ASPH 3239/4885
US-12018017-B2 Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof BAD, CASP1, BAX PIK3R1 1426/4885PIK3CA 1906/4885ASPH 2231/4885
US-20060205736-A1 Sulfonyl-substituted bicyclic compounds as modulators of PPAR PPARG, PPARA, PPARD PIK3R1 1336/4885PIK3CA 1921/4885ASPH 3890/4885
US-20230365606-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OXER1, OPRD1, OXSR1 PIK3R1 2612/4885PIK3CA 3649/4885ASPH 4573/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.